GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dynatronics Corp (NAS:DYNT) » Definitions » ROE %

Dynatronics (Dynatronics) ROE % : -25.22% (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Dynatronics ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Dynatronics's annualized net income for the quarter that ended in Dec. 2023 was $-4.04 Mil. Dynatronics's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $16.04 Mil. Therefore, Dynatronics's annualized ROE % for the quarter that ended in Dec. 2023 was -25.22%.

The historical rank and industry rank for Dynatronics's ROE % or its related term are showing as below:

DYNT' s ROE % Range Over the Past 10 Years
Min: -33.8   Med: -16.88   Max: 8.81
Current: -28.04

During the past 13 years, Dynatronics's highest ROE % was 8.81%. The lowest was -33.80%. And the median was -16.88%.

DYNT's ROE % is ranked worse than
68.8% of 811 companies
in the Medical Devices & Instruments industry
Industry Median: 0.31 vs DYNT: -28.04

Dynatronics ROE % Historical Data

The historical data trend for Dynatronics's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynatronics ROE % Chart

Dynatronics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.38 -16.85 8.81 -16.91 -25.80

Dynatronics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.14 -25.12 -52.81 -7.93 -25.22

Competitive Comparison of Dynatronics's ROE %

For the Medical Devices subindustry, Dynatronics's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dynatronics's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dynatronics's ROE % distribution charts can be found below:

* The bar in red indicates where Dynatronics's ROE % falls into.



Dynatronics ROE % Calculation

Dynatronics's annualized ROE % for the fiscal year that ended in Jun. 2023 is calculated as

ROE %=Net Income (A: Jun. 2023 )/( (Total Stockholders Equity (A: Jun. 2022 )+Total Stockholders Equity (A: Jun. 2023 ))/ count )
=-4.973/( (21.699+16.857)/ 2 )
=-4.973/19.278
=-25.80 %

Dynatronics's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-4.044/( (16.545+15.53)/ 2 )
=-4.044/16.0375
=-25.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Dynatronics  (NAS:DYNT) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-4.044/16.0375
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-4.044 / 32.604)*(32.604 / 29.823)*(29.823 / 16.0375)
=Net Margin %*Asset Turnover*Equity Multiplier
=-12.4 %*1.0933*1.8596
=ROA %*Equity Multiplier
=-13.56 %*1.8596
=-25.22 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-4.044/16.0375
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-4.044 / -4.048) * (-4.048 / -3.608) * (-3.608 / 32.604) * (32.604 / 29.823) * (29.823 / 16.0375)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.999 * 1.122 * -11.07 % * 1.0933 * 1.8596
=-25.22 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Dynatronics ROE % Related Terms

Thank you for viewing the detailed overview of Dynatronics's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dynatronics (Dynatronics) Business Description

Traded in Other Exchanges
N/A
Address
1200 Trapp Road, Eagan, MN, USA, 55121
Dynatronics Corp is a United States-based company that is engaged in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, rehabilitation equipment, custom athletic training treatment tables and equipment, institutional cabinetry as well as other rehabilitation and therapy products and supplies. The company markets and sells its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions. It offers customers a one-stop-shop for their medical equipment and supply needs, including electrotherapy, therapeutic ultrasound, phototherapy, rehabilitation products, treatment tables, customized training room products, and exercise products.
Executives
Gabriel Ellwein officer: Chief Financial Officer 4782 HIGHCROFT COURT, EAGAN MN 55122
John Anthony Krier director, officer: Chief Executive Officer 319 WEST 50TH SOUTH, MINNEAPOLIS MN 55419
David B Holtz director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Scott Klosterman director
R Scott Ward director 1064 S. CRESTVIEW CIRCLE, SLC VA 84108
Stuart Essig 10 percent owner 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Erin S. Enright director 666 PLAINSBORO ROAD, PLAINSBORO NJ 08536
Brian Larkin director INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Brian D. Baker officer: Chief Operating Officer C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Provco Ventures 1 Lp 10 percent owner 795 E LANCASTER AVE SUITE 200, VILLANOVA PA 19085
Norman Iii Roegner officer: Chief Financial Officer 1200 TRAPP ROAD, EAGAN MN 55121
Skyler N Black officer: Corporate Controller 1448 E LEXI LN, COTTONWOOD HEIGHTS UT 84093
Keeler Jennifer Bennett Bennett officer: Secretary / General Counsel 8620 STILLWATER BLVD N, LAKE ELMO MN 55042
Daryl Connell officer: Chief Information Officer 932 MINJON DRIVE, APPLE VALLEY MN 55124
Cynthia L. Mchenry officer: VP, Operations 7030 PARK CENTRE DRIVE, COTTONWOOD HEIGHTS UT 84121